Description

1'-Oxo-Spiro[Cyclohexane-1,3'(1'H)-Furo[3,4-C]Pyridine]-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its complex spirocyclic and fused heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents, especially within neurological and metabolic disorder research.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates targeting complex biological pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• API Development: Serves as a critical precursor in the multi-step synthesis of potential active pharmaceutical ingredients.
• Biochemical Research: May be utilized as a tool compound or ligand in biochemical assays and target validation studies.
• Custom Synthesis: Employed by contract research and manufacturing organizations (CROs/CMOs) for client-specific molecule development.
• Academic Research: Used in university and institutional labs for exploratory synthetic chemistry and pharmacological studies.

Basic Information

Product Name	1'-Oxo-Spiro[Cyclohexane-1,3'(1'H)-Furo[3,4-C]Pyridine]-4-Carboxylic Acid
CAS No.	569351-62-8
Molecular Formula	C14H15NO4
Molecular Weight	261.27 g/mol
Synonyms	1'-Oxospiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid; 4-Carboxy-1'-oxospiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]; Spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid, 1'-oxo-; 1'-Oxo-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-carboxylic acid; 569351-62-8; Furo[3,4-c]pyridine-4-carboxylic acid, 1,1a,4,5-tetrahydro-1'-oxospiro[cyclohexane-1,3'-]-; Spirocyclic furopyridine carboxylic acid derivative.
EINECS	Contact for details

Quality Control

Our 1'-Oxo-Spiro[Cyclohexane-1,3'(1'H)-Furo[3,4-C]Pyridine]-4-Carboxylic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.